Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 25 | 2023 | 105 | 4.650 |
Why?
|
| Republic of Korea | 62 | 2023 | 103 | 2.960 |
Why?
|
| Incidence | 50 | 2024 | 882 | 2.230 |
Why?
|
| Risk Factors | 69 | 2024 | 3414 | 2.090 |
Why?
|
| Stroke | 13 | 2023 | 274 | 1.820 |
Why?
|
| Cohort Studies | 33 | 2024 | 1422 | 1.290 |
Why?
|
| Middle Aged | 70 | 2023 | 9642 | 1.260 |
Why?
|
| Tuberculosis | 6 | 2023 | 56 | 1.260 |
Why?
|
| Hypertension | 7 | 2024 | 770 | 1.250 |
Why?
|
| Aged | 53 | 2023 | 6448 | 1.240 |
Why?
|
| Mushroom Bodies | 2 | 2020 | 3 | 1.220 |
Why?
|
| Diabetes Mellitus | 5 | 2024 | 465 | 1.210 |
Why?
|
| Bronchiectasis | 5 | 2023 | 9 | 1.130 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2023 | 160 | 1.110 |
Why?
|
| Kidney Failure, Chronic | 3 | 2023 | 231 | 1.080 |
Why?
|
| Humans | 104 | 2024 | 34853 | 1.050 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2023 | 22 | 1.040 |
Why?
|
| Keratosis, Actinic | 2 | 2021 | 4 | 1.010 |
Why?
|
| Male | 75 | 2023 | 18870 | 1.000 |
Why?
|
| Female | 76 | 2023 | 19873 | 1.000 |
Why?
|
| Myocardial Infarction | 8 | 2023 | 221 | 0.970 |
Why?
|
| Adult | 56 | 2023 | 11034 | 0.960 |
Why?
|
| Proportional Hazards Models | 18 | 2023 | 423 | 0.940 |
Why?
|
| Psoriasis | 5 | 2021 | 17 | 0.920 |
Why?
|
| Drosophila Proteins | 3 | 2014 | 162 | 0.920 |
Why?
|
| Databases, Factual | 14 | 2022 | 288 | 0.910 |
Why?
|
| Acetylcholine | 1 | 2022 | 68 | 0.890 |
Why?
|
| Nutrition Surveys | 10 | 2020 | 228 | 0.880 |
Why?
|
| Lung Neoplasms | 5 | 2023 | 336 | 0.860 |
Why?
|
| Synaptic Transmission | 1 | 2022 | 141 | 0.840 |
Why?
|
| Neurons | 3 | 2020 | 1130 | 0.770 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2020 | 5 | 0.760 |
Why?
|
| Dementia | 4 | 2023 | 133 | 0.750 |
Why?
|
| Receptors, Dopamine | 1 | 2020 | 21 | 0.740 |
Why?
|
| Association Learning | 1 | 2020 | 29 | 0.740 |
Why?
|
| Smell | 1 | 2020 | 35 | 0.740 |
Why?
|
| Dementia, Vascular | 4 | 2023 | 34 | 0.690 |
Why?
|
| Sleep | 2 | 2017 | 122 | 0.670 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 592 | 0.670 |
Why?
|
| Anticoagulants | 5 | 2023 | 97 | 0.610 |
Why?
|
| Population Surveillance | 6 | 2021 | 231 | 0.610 |
Why?
|
| Smoking | 10 | 2022 | 903 | 0.610 |
Why?
|
| Drosophila melanogaster | 3 | 2020 | 168 | 0.600 |
Why?
|
| Peptic Ulcer | 1 | 2016 | 9 | 0.600 |
Why?
|
| Anemia | 4 | 2021 | 45 | 0.570 |
Why?
|
| Diabetic Retinopathy | 4 | 2018 | 65 | 0.570 |
Why?
|
| Laryngeal Neoplasms | 3 | 2021 | 11 | 0.570 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2021 | 41 | 0.560 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2022 | 60 | 0.560 |
Why?
|
| Hemoglobins | 3 | 2021 | 101 | 0.540 |
Why?
|
| Prevalence | 16 | 2020 | 1425 | 0.530 |
Why?
|
| Heart Failure | 4 | 2022 | 230 | 0.520 |
Why?
|
| Prediabetic State | 3 | 2022 | 51 | 0.510 |
Why?
|
| Oviposition | 1 | 2014 | 12 | 0.510 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 628 | 0.510 |
Why?
|
| Retrospective Studies | 15 | 2024 | 1961 | 0.510 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 69 | 0.480 |
Why?
|
| Appetitive Behavior | 1 | 2013 | 11 | 0.460 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2013 | 21 | 0.460 |
Why?
|
| Aged, 80 and over | 15 | 2021 | 2333 | 0.450 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 124 | 0.450 |
Why?
|
| Tachycardia, Ventricular | 2 | 2023 | 11 | 0.440 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 59 | 0.440 |
Why?
|
| Neoplasms | 2 | 2021 | 1033 | 0.440 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 881 | 0.420 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2023 | 9 | 0.410 |
Why?
|
| Ventricular Premature Complexes | 2 | 2021 | 10 | 0.400 |
Why?
|
| Alcohol Drinking | 7 | 2021 | 490 | 0.400 |
Why?
|
| Albuminuria | 3 | 2017 | 76 | 0.400 |
Why?
|
| Parkinson Disease | 2 | 2024 | 167 | 0.390 |
Why?
|
| Case-Control Studies | 7 | 2021 | 1056 | 0.390 |
Why?
|
| Disease Susceptibility | 5 | 2021 | 92 | 0.390 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 143 | 0.390 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 964 | 0.380 |
Why?
|
| Signal Transduction | 2 | 2020 | 1802 | 0.370 |
Why?
|
| National Health Programs | 5 | 2021 | 18 | 0.370 |
Why?
|
| Young Adult | 16 | 2023 | 4012 | 0.370 |
Why?
|
| Brain Infarction | 2 | 2020 | 20 | 0.360 |
Why?
|
| Sexual Behavior, Animal | 1 | 2010 | 51 | 0.360 |
Why?
|
| Comorbidity | 6 | 2021 | 606 | 0.360 |
Why?
|
| Body Height | 2 | 2021 | 52 | 0.350 |
Why?
|
| Health Surveys | 3 | 2020 | 358 | 0.350 |
Why?
|
| Cause of Death | 5 | 2022 | 154 | 0.340 |
Why?
|
| Life Style | 2 | 2021 | 288 | 0.340 |
Why?
|
| Risk Assessment | 7 | 2021 | 727 | 0.340 |
Why?
|
| Hearing Loss | 2 | 2020 | 11 | 0.330 |
Why?
|
| Brain Ischemia | 2 | 2022 | 179 | 0.330 |
Why?
|
| Obesity | 8 | 2023 | 965 | 0.320 |
Why?
|
| Behavior, Animal | 2 | 2020 | 304 | 0.320 |
Why?
|
| Drosophila | 2 | 2022 | 133 | 0.310 |
Why?
|
| Body Mass Index | 6 | 2023 | 775 | 0.310 |
Why?
|
| Blood Glucose | 4 | 2023 | 333 | 0.310 |
Why?
|
| Thinness | 3 | 2022 | 29 | 0.310 |
Why?
|
| Aging | 2 | 2022 | 639 | 0.300 |
Why?
|
| Stomach Neoplasms | 2 | 2019 | 192 | 0.290 |
Why?
|
| Prognosis | 7 | 2023 | 707 | 0.280 |
Why?
|
| Korea | 4 | 2019 | 43 | 0.280 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 413 | 0.270 |
Why?
|
| Depression | 2 | 2021 | 664 | 0.260 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 23 | 0.260 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 26 | 0.250 |
Why?
|
| Longitudinal Studies | 6 | 2023 | 841 | 0.250 |
Why?
|
| Animals | 6 | 2022 | 14307 | 0.250 |
Why?
|
| Arteritis | 1 | 2024 | 1 | 0.250 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2024 | 1 | 0.250 |
Why?
|
| Waist Circumference | 3 | 2021 | 82 | 0.250 |
Why?
|
| Blood Pressure | 3 | 2024 | 613 | 0.240 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2023 | 16 | 0.240 |
Why?
|
| Multivariate Analysis | 7 | 2021 | 570 | 0.240 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 11 | 0.240 |
Why?
|
| Registries | 3 | 2021 | 330 | 0.240 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 17 | 0.240 |
Why?
|
| Hip Fractures | 1 | 2023 | 26 | 0.230 |
Why?
|
| Administration, Oral | 5 | 2023 | 212 | 0.230 |
Why?
|
| Dermatitis, Atopic | 1 | 2023 | 10 | 0.230 |
Why?
|
| Fractures, Bone | 1 | 2023 | 51 | 0.230 |
Why?
|
| Wet Macular Degeneration | 1 | 2023 | 3 | 0.230 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 52 | 0.230 |
Why?
|
| Causality | 1 | 2022 | 45 | 0.230 |
Why?
|
| Pancreatitis | 1 | 2022 | 16 | 0.220 |
Why?
|
| Behcet Syndrome | 1 | 2022 | 2 | 0.220 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 72 | 0.220 |
Why?
|
| Weight Gain | 2 | 2020 | 128 | 0.220 |
Why?
|
| Overweight | 3 | 2022 | 233 | 0.210 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2022 | 16 | 0.210 |
Why?
|
| Nasal Obstruction | 1 | 2021 | 3 | 0.210 |
Why?
|
| Migraine Disorders | 1 | 2021 | 6 | 0.210 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 137 | 0.210 |
Why?
|
| Nasal Septum | 1 | 2021 | 4 | 0.210 |
Why?
|
| Ventricular Fibrillation | 1 | 2021 | 8 | 0.210 |
Why?
|
| Lung Diseases | 1 | 2022 | 56 | 0.210 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2021 | 3 | 0.210 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 9 | 0.210 |
Why?
|
| Uvula | 1 | 2021 | 1 | 0.210 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 11 | 0.210 |
Why?
|
| Palate | 1 | 2021 | 7 | 0.200 |
Why?
|
| Pharynx | 1 | 2021 | 12 | 0.200 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 181 | 0.200 |
Why?
|
| Diabetes Complications | 1 | 2021 | 91 | 0.200 |
Why?
|
| Appendectomy | 1 | 2020 | 16 | 0.200 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 292 | 0.190 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 18 | 0.190 |
Why?
|
| Vitiligo | 1 | 2020 | 3 | 0.190 |
Why?
|
| Vision, Low | 1 | 2020 | 13 | 0.190 |
Why?
|
| Body Weight | 2 | 2021 | 404 | 0.190 |
Why?
|
| Octopamine | 1 | 2020 | 9 | 0.190 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 73 | 0.190 |
Why?
|
| Treatment Outcome | 5 | 2023 | 1349 | 0.190 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 56 | 0.190 |
Why?
|
| Cholesterol | 1 | 2021 | 194 | 0.190 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 284 | 0.190 |
Why?
|
| Postmenopause | 2 | 2022 | 125 | 0.180 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 93 | 0.180 |
Why?
|
| Hyperuricemia | 1 | 2019 | 10 | 0.180 |
Why?
|
| Mycobacterium Infections | 1 | 2019 | 16 | 0.180 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 7 | 0.180 |
Why?
|
| Mouth Neoplasms | 1 | 2020 | 70 | 0.180 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 105 | 0.180 |
Why?
|
| Cognition | 1 | 2022 | 373 | 0.180 |
Why?
|
| Sex Characteristics | 1 | 2021 | 213 | 0.180 |
Why?
|
| Postoperative Complications | 1 | 2020 | 206 | 0.170 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2024 | 19 | 0.170 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 147 | 0.170 |
Why?
|
| Disabled Persons | 1 | 2019 | 60 | 0.170 |
Why?
|
| Asthma | 1 | 2023 | 363 | 0.170 |
Why?
|
| Thiazoles | 1 | 2019 | 71 | 0.170 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 35 | 0.170 |
Why?
|
| Pyridines | 1 | 2019 | 113 | 0.170 |
Why?
|
| Dopamine | 1 | 2020 | 232 | 0.170 |
Why?
|
| Ethanol | 1 | 2020 | 188 | 0.160 |
Why?
|
| Vitamin K | 1 | 2017 | 6 | 0.160 |
Why?
|
| Fibrosis | 3 | 2023 | 146 | 0.160 |
Why?
|
| Dysphonia | 1 | 2017 | 4 | 0.160 |
Why?
|
| Thromboembolism | 1 | 2017 | 14 | 0.160 |
Why?
|
| Proteinuria | 1 | 2017 | 48 | 0.150 |
Why?
|
| Logistic Models | 5 | 2019 | 894 | 0.150 |
Why?
|
| Alcoholism | 1 | 2020 | 220 | 0.150 |
Why?
|
| Hemorrhage | 3 | 2023 | 46 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 63 | 0.150 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 42 | 0.150 |
Why?
|
| Exercise | 4 | 2023 | 524 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 51 | 0.150 |
Why?
|
| Dyslipidemias | 1 | 2017 | 42 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 151 | 0.140 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 8 | 0.140 |
Why?
|
| Risk | 3 | 2021 | 256 | 0.140 |
Why?
|
| Drug Therapy, Combination | 3 | 2022 | 217 | 0.140 |
Why?
|
| Laryngitis | 1 | 2015 | 2 | 0.140 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 15 | 0.140 |
Why?
|
| Blepharoptosis | 1 | 2015 | 3 | 0.140 |
Why?
|
| Tinnitus | 1 | 2015 | 2 | 0.140 |
Why?
|
| Health | 1 | 2015 | 28 | 0.130 |
Why?
|
| Particulate Matter | 1 | 2015 | 49 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 446 | 0.130 |
Why?
|
| Anxiety | 1 | 2021 | 705 | 0.130 |
Why?
|
| Oviducts | 1 | 2014 | 13 | 0.130 |
Why?
|
| Infertility, Female | 1 | 2014 | 24 | 0.130 |
Why?
|
| Smoking Cessation | 1 | 2020 | 487 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 70 | 0.120 |
Why?
|
| Infant | 3 | 2023 | 1014 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2015 | 177 | 0.120 |
Why?
|
| Vitamin D | 1 | 2014 | 176 | 0.110 |
Why?
|
| Survivors | 2 | 2023 | 126 | 0.110 |
Why?
|
| Sex Factors | 3 | 2021 | 859 | 0.100 |
Why?
|
| Warfarin | 2 | 2023 | 59 | 0.100 |
Why?
|
| Quality of Life | 1 | 2015 | 459 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 859 | 0.100 |
Why?
|
| Sex Attractants | 1 | 2010 | 3 | 0.090 |
Why?
|
| Genes, Insect | 1 | 2010 | 20 | 0.090 |
Why?
|
| Touch | 1 | 2010 | 15 | 0.090 |
Why?
|
| Vibration | 1 | 2010 | 21 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 794 | 0.090 |
Why?
|
| Vocalization, Animal | 1 | 2010 | 18 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1426 | 0.080 |
Why?
|
| Creatinine | 2 | 2019 | 101 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 338 | 0.080 |
Why?
|
| Age Factors | 2 | 2021 | 1007 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 608 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 517 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 1023 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 2 | 2015 | 125 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 2561 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2010 | 653 | 0.060 |
Why?
|
| Adolescent | 3 | 2021 | 5035 | 0.060 |
Why?
|
| Rifampin | 1 | 2023 | 3 | 0.060 |
Why?
|
| Child | 2 | 2021 | 2875 | 0.060 |
Why?
|
| Antitubercular Agents | 1 | 2023 | 27 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2023 | 93 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 141 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 40 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 87 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2021 | 12 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 1 | 0.050 |
Why?
|
| Oral Surgical Procedures | 1 | 2021 | 4 | 0.050 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2021 | 2 | 0.050 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2021 | 15 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2021 | 18 | 0.050 |
Why?
|
| Estrogens | 1 | 2022 | 190 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 114 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2021 | 154 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 26 | 0.050 |
Why?
|
| Survival Rate | 1 | 2021 | 310 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2019 | 7 | 0.050 |
Why?
|
| Visual Acuity | 1 | 2020 | 98 | 0.050 |
Why?
|
| Chest Pain | 1 | 2020 | 36 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2018 | 17 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 68 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 145 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2019 | 22 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2019 | 35 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2018 | 28 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 871 | 0.040 |
Why?
|
| Weight Loss | 1 | 2019 | 124 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 392 | 0.040 |
Why?
|
| Mortality | 1 | 2018 | 150 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 528 | 0.040 |
Why?
|
| Fasting | 1 | 2017 | 50 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 1003 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 1318 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 424 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2017 | 322 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2017 | 429 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 1503 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 151 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1300 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 223 | 0.030 |
Why?
|
| Particle Size | 1 | 2015 | 200 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 26 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 152 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 188 | 0.030 |
Why?
|
| Lipids | 1 | 2015 | 222 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 1353 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2015 | 469 | 0.030 |
Why?
|